Search clinical trials for: Amlodipine, valsartan drug combination

Total 5388 results

Hospital Moinhos de Vento
Ministry of Health, Brazil; World Stroke Organization

Recruiting

Polipill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE) (PROMOTE)

Stroke | Cognitive Decline

Brazil
Novartis Pharmaceuticals

Completed

Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event (TRANSITION)

Heart Failure With Reduced Ejection Fraction

Italy, Czechia, Russian Federation, Saudi Arabia, Turkey, Belgium, Switzerland, United Kingdom, Spain, Canada, Lebanon, Germany, Slovakia, Portugal, France, Poland, Argentina, Norway, Sweden
Brigham and Women's Hospital
Novartis Pharmaceuticals

Withdrawn

Comparing ARNI With ACE Inhibitor on Endothelial Function (PARADOR)

Heart Failure With Reduced Ejection Fraction
Novartis Pharmaceuticals

Recruiting

Special Drug Use Surveillance of Entresto Tablets (Hypertension) (ENLIGHT)

Hypertension

Japan
Novartis Pharmaceuticals

Completed

A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension

Essential Hypertension

China, Taiwan, Japan, Thailand, Korea, Republic of
HK inno.N Corporation

Completed

Bioequivalence Study of CJ-30060 in Healthy Male Volunteers

Healthy Male Subjects

Korea, Republic of
Boehringer Ingelheim

Withdrawn

Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice

Hypertension

Japan
Novartis Pharmaceuticals

Completed

Safety and Tolerability and Efficacy of LCZ696 in Japanese Severe Hypertensive Patients

Severe Hypertension

Japan
Novartis Pharmaceuticals

Completed

Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI (PARADISE-MI)

Acute Myocardial Infarction

China, United States, South Africa, Italy, Spain, Croatia, Czechia, Hungary, Romania, Taiwan, Belgium, Germany, Netherlands, Austria, Denmark, United Kingdom, Thailand, Argentina, Israel, Australia, Bulgaria, France, Greece, Russian Federation and more
Mohammed Alnims

Completed

Six Months Clinical and Echocardiographic Outcome of ARNI LCZ696 Therapy in HFrEF Patients

Heart Failure With Reduced Ejection Fraction

Egypt
Central Hospital, Izmir

Unknown

Changes in Intrathoracic Impedance During Sacubitril/Valsartan Treatment (CHILISALT)

Heart Failure With Reduced Ejection Fraction
Novartis Pharmaceuticals

Completed

Efficacy and Safety of LCZ696 Compared to Placebo in Patients With Essential Hypertension

Hypertension

China, Taiwan, Japan, Thailand, Korea, Republic of
HK inno.N Corporation

Unknown

Bioequivalence Study of CJ-30060 in Healthy Volunteers

Healthy Subjects

Korea, Republic of
Oslo University Hospital
University of Oslo

Completed

Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension (VALUE)

Essential Hypertension
University of Leeds
The Leeds Teaching Hospitals NHS Trust

Completed

Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression

Hypertension | Left Ventricular Hypertrophy

United Kingdom
University of Minnesota
American Heart Association

Terminated

Use of Entresto Sacubitril/Valsartan for the Treatment of Peripheral Arterial Disease

Peripheral Arterial Disease

United States
Daiichi Sankyo, Inc.

Completed

Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension

Essential Hypertension

Italy, Poland, Ukraine, Germany, Spain, Bulgaria, Romania, Denmark, Belgium, Netherlands, Russian Federation, Hungary, Slovakia, Czechia, Latvia
University Medical Centre Ljubljana

Completed

Post- Myocardial Infarction Arterial Wall Improvement by Low-dose Fluvastatin and Valsartan

Myocardial Infarction

Slovenia
First Affiliated Hospital Xi'an Jiaotong University
Baoji Central Hospital; First Affiliated Hospital Xi'an Medical University

Unknown

Effect of Angiotensin-Neprilysin Inhibition (ARNI) on Prognosis of Chronic Heart Failure

Chronic Heart Failure

China
Novartis Pharmaceuticals

Completed

Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction (EVALUATE-HF)

Heart Failure and Reduced Ejection Fraction

United States
RenJi Hospital

Unknown

Early Treatment of ARNI on Myocardial Remodeling and Progress

Myocardial Infarction

China
Acrobat Trial Group

Unknown

ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing (ACROBAT) (ACROBAT)

Hypertension and Atrial Fibrillation

Japan
Novartis Pharmaceuticals

Terminated

Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM) (RHYTHM)

Heart Failure

China
Shanghai Jiao Tong University School of Medicine

Recruiting

Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension

Isolated Systolic Hypertension

China
HK inno.N Corporation

Completed

Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male Subjects

Healthy

Korea, Republic of
Yuhan Corporation

Completed

Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia

Hypertension | Hyperlipidemia

Korea, Republic of
Boryung Pharmaceutical Co., Ltd
Kyunghee university hospital A Drug Analytical Laboratory

Completed

To Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual Tablets

Hypertension

Korea, Republic of
Boehringer Ingelheim

Completed

Influence of Food on the Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Japanese Male Volunteers

Healthy
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia (JEWEL I)

Hypertension | Dyslipidemia

Canada, United Kingdom
Boehringer Ingelheim

Completed

Pharmacokinetics of Different Formulations of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ) in Japanese Healthy Male Volunteers

Healthy

Japan
The Cleveland Clinic

Recruiting

Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study (SEAL-IT)

Stage D Heart Failure

United States
Boehringer Ingelheim

Completed

Bioequivalence of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers

Healthy
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels (GEMINI-AALA)

Hypertension | Hyperlipidemia

Brazil, Turkey, Taiwan, Argentina, India, Philippines, Singapore, Thailand, Australia, Chile, South Africa, Jordan, Korea, Republic of, Lebanon, United Arab Emirates, Malaysia, Peru, Israel, Indonesia, Guatemala, Hong Kong, Kuwait, ... and more
University of Roma La Sapienza

Unknown

Low-dose Combination of Three Antihypertensive Drugs (3D)

Arterial Hypertension

Italy
Research Institute for Complex Problems of Cardiovascular...

Completed

Left Atrial Mechanical Function Improvement After Atrial Fibrillation Catheter Ablation

Atrial Fibrillation
Boehringer Ingelheim

Completed

Filtered Trial for Telmisartan 40mg Non-responder

Hypertension

Japan
Boehringer Ingelheim

Completed

TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switch

Hypertension

Germany, Italy, Mexico, Netherlands, Poland
Mayo Clinic
National Institute on Aging (NIA)

Completed

Circulating NEP and NEP Inhibition Study in Heart Failure With Preserved Ejection Fraction (CNEPi)

Heart Failure With Preserved Ejection Fraction

United States
Shanghai Jiao Tong University School of Medicine

Recruiting

Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation

Hypertension | Atrial Fibrillation

China
Boehringer Ingelheim

Completed

Telmisartan 80mg Non-responder Trial

Hypertension

Japan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Hypertension | Angina Pectoris | Hypercholesterolemia | Familial Hypercholesterolemia
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia. (JEWEL II)

Hypertension | Hyperlipidemia

Greece, Austria, Finland, Italy, Hungary, Belgium, Spain, Ireland, Portugal, Slovenia, Switzerland
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population (CAPABLE)

Hypertension | Dyslipidemia

United States
Novartis Pharmaceuticals

Completed

Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood Pressure

Hypertension

Sweden, Belgium, Hungary, India, Italy, Poland, Turkey, United States, Brazil, France, South Africa
Yuhan Corporation

Completed

Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan

Hypertension | Hyperlipidemia

Korea, Republic of
JW Pharmaceutical

Completed

Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects

Hypertension | Hyperlipidemia

Korea, Republic of
Mayo Clinic

Recruiting

PDD in Type 2 Diabetes w/wo Diastolic Dysfunction

Diabetes Mellitus, Type 2 | Diastolic Dysfunction

United States
Brigham and Women's Hospital

Terminated

Assessment of Renin Inhibition on Insulin Sensitivity, Diastolic Function and Aortic Compliance

Insulin Sensitivity | Diastolic Function | Aortic Compliance

United States
Yuhan Corporation

Completed

Efficacy & Safety Study of YH22162 vs Telmisartan/Amlodipine in Patients With Hypertension Inappropriately Controlled on Telmisartan/Amlodipine Treatment

Hypertension

Korea, Republic of
Novartis Pharmaceuticals

Completed

Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications (Navigator)

Diabetes Mellitus, Type 2

Austria, Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark, Ecuador, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Italy, Malaysia, Mexico, Netherlands, Norway, Peru, Poland, Russian Federation and more

Search clinical trials for: Amlodipine, valsartan drug combination

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations